With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
July 3, 2017. We're getting smarter at prostate cancer treatment, but not necessarily in the way of other rapidly evolving cancer care (read: immunotherapy). This week’s JAMA review outlines how nuances in risk stratifications employing novel imaging techniques and biomarkers have led to fine-tuning treatment algorithms. This has not only improved survival but also drastically decreased morbidity. And that’s why knowing when (and when not) to treat can sometimes be the greatest advancement of all.